Tuesday, 17 March 2020 | Nina Klein

How Much Does Stem Cell Therapy Cost?

If you, or perhaps someone close to you, suffers with a challenging illness, you may be exploring viable alternative treatments. You may even have come across stem cell therapy as an avenue to explore.

But where do you start? And could you even afford it?

It’s perfectly okay to be overwhelmed at first, with plenty to consider. First of all, how do you get stem cells? Is there a stem cell market of sorts? And how do you even find a suitable stem cell clinic?

We’re here to answer all of your questions in detail. And more importantly, we’ll give you the reported average fees for stem cell therapy for different parts of the body and various diseases.

Stem Cell Therapy Procedures

At first glance, the costs of stem cell-based therapies may come as a shock. The reason it can be more expensive than other treatments is that there are many procedures involved related to product safety and production in general. Additionally, innovative therapies tend to be more expensive than established therapies.

Here are the basic procedures involved in stem cell-based therapy:

  • Diagnostics: The condition of the patient will be evaluated, including medical history, ongoing treatments, current health status, etc.
  • Specific pre-treatment testing: Patients will be tested to determine if they are eligible for treatment with stem cell therapy.
  • Harvesting stem cells: The stem cells are obtained from the patient (or a donor). This procedure is highly dependent on what type of stem cell will be used and from which tissue source it comes from. In some clinics, they use stem cells from the bone marrow. Others also use adult stem cells gathered from fat cells.
  • Transplantation / application of stem cells: Stem cells or its secretome are applied to the patient.
  • Recovery: Patients who need to stay in the hospital due to their condition will need this time to rest and avoid infection. This is not the case for most stem cell therapies. Most treatments are on an outpatient basis, which means that patients can simply check out of the clinic and return for their next session.
  • Post-treatment monitoring: Patients will be monitored for progress. The patient’s physician can continue to coordinate with the stem cell clinic for updates about the patient’s condition.

Average Costs for Stem Cell Therapy for Different Parts of the Body

Many clinics do not publish rates for their treatments, but journalists have reported on the cost of stem cell-based therapies in countries like the US and Canada. Below we list the standard published rates, according to these reports.

It should be noted that from these costs a patient can not directly derivate how effective or safe a treatment is. But generally speaking, especially when it comes to stem cells and their medical application, the necessary laboratory tests to make a product safe and efficient are usually very costly, and will obviously increase the price.

If a treatment is very inexpensive, patients should consider investigating if the price may come with disadvantages regarding product safety and efficiency.

Please also note that these costs do not represent ANOVA prices. If you are interested in a treatment at ANOVA IRM, please get in touch with us to receive a rate.

Cost of Stem Cell Knee Injections

The average cost of stem cell treatment for knees is around USD 3,000 to USD 5,000 per knee. There may be multiple factors that can contribute to this cost, including the gravity of the knee injury and the country where the clinic is located.

Cost of Stem Cell Treatment for Erectile Dysfunction

There are published reports online for stem cell-based treatments for men with erectile dysfunction. They are known to cost from USD 5,000 up to USD 20,000, depending on the particular condition of the patient.

 

Cost of Stem Cell Therapy for Back Pain

The cost of a stem cell treatment for back pain, such as a spinal injections or injections for disc regeneration, may range from USD 5,000 to USD 7,000, according to published reports. Of course, finding the right clinic is very important.

More and more people are considering stem cell therapy for back pain since the overall costs for traditional methods can be costlier than the stem cell-based therapy.

 

Cost for Stem Cell Therapy for Stroke

In stem cell clinics in Europe, a patient suffering from the effects of a stroke will have to shell out around USD 25,000 to USD 30,000. In other countries outside the EU, it may cost you USD 7,000 to USD 8,000.

Cost for Stem Cell Treatment for Spinal Cord Injury

Similar to back pain, the spinal cord is also a sensitive area. Stem cell therapy for a spinal cord injury may set you back around USD 7,000.

Cost for Stem Cell Treatment for Arthritis

Patients who have arthritis usually get a stem cell injection for their knees, which costs approximately USD 3,000 to USD 5,000 per knee.

Cost of Stem Cell Therapy for Hips

Patients who have problems with their hips very often suffer with arthritis. The cost of using stem cell therapy to improve the condition of one’s hips start at USD 5,000.

How Much do Stem Cell Injections Cost?

The price range of stem cell injections (also sometimes called "stem cell shots") is a very commonly asked question. Many curious people even ask if they can avail of the injection right away, as if it was a flu shot.

In this section, we will discuss stem cell injections and how getting a proper treatment may not be as easy as injecting a body part with stem cells.

Stem Cell Injections vs. Stem Cell Therapy

Many people interchange the use of stem cell therapy and stem cell injection, but the two are not the same. Stem cell injections are just one part of the whole process of stem cell therapy, which may also include a comprehensive diagnostic of the patient, the harvesting of the stem cells from themselves or a donor, and more.

If some clinics are advertising their stem cell costs without getting to know the condition of the patient, beware. An effective stem cell-based treatment should always consider the patient’s medical history before administering an injection or any other type of treatment.

In the US, stem cell injections can cost from USD 4,000 to USD 8,000. Again, this usually does not include all associated costs that come with a stem cell treatment such as diagnostics and tissue harvesting.

How Long do Stem Cell Injections Last?

When coping with pain and discomfort, it is understandable that patients are keen to know how many sessions of injections they should get to see improvements. It’s also understandable that they want to be prepared for the expenses of needing multiple sessions.

Unfortunately, the answer to this one is more complicated than giving a specific number of sessions. Progress depends on a patient’s health, medical history, and other treatments being undertaken. There are times when a combination of several treatments has helped speed up recovery, but on other occasions it can drag on.

A doctor may give an estimate of how many sessions it may take before one can experience progress, but this can only be advised after a thorough diagnosis of the patient’s condition. Do you want to receive an estimation from us? Please get in touch to schedule a consultation with our doctors.

How Much Does a Stem Cell Transplant Cost?

Aside from stem cell injections, another term that many people ask about is a stem cell transplant. What exactly is the difference between a stem cell transplant, a stem cell injection, and a stem cell therapy?

Stem Cell Therapy vs. Stem Cell Injection vs. Stem Cell Transplant

First, let’s clarify the definition of stem cell therapy. In a nutshell, stem cell therapy involves a series of procedures using stem cells, aimed at improving one’s condition or for treatment of a disease.

Part of the therapy includes the diagnostics, the harvesting of stem cells, the injection, etc. The stem cells in the injection can either come from the patients themselves or from another source. Donors are usually relatives or someone with a compatible blood type.

A stem cell transplant, by definition, involves harvesting the stem cells from a person’s body, to be transplanted to someone else’s body. This is most often because the patients themselves do not have enough healthy stem cells.

This usually happens after chemotherapy or radiotherapy when cancer cells are killed, but unfortunately, during this process, stem cells in the bone marrow are destroyed too.

In some cases, doctors can also collect a patient’s own stem cells before these procedures, providing that a patient’s own stem cells are healthy enough.

Stem cell transplants are often used to treat people with leukemia, myeloma, or lymphoma.

At ANOVA, we do not perform stem cell transplants. We solely use stem cells from the patient’s own tissue. The patient is thus his or her own donor.

Stem Cell Transplant Costs for Cancer Patients

A lot of recipients of stem cell transplants are patients suffering from various types of cancer. Stem cell transplants can cost anywhere from USD 350,000 to USD 800,000. Unfortunately, a lot of insurers consider stem cell transplant as an experimental procedure and may not cover the costs of such treatments. Check if your insurance provider includes stem cell therapy in your plan when you consider this treatment.

How Much Does Stem Cell Exosome Therapy Cost?

Exosomes are one component of the Stem Cell Secretome Therapy. And Stem Cell Secretome is a stem-cell based treatment where only the biologically active compounds are applied to the body. Read more about Stem Cell Secretome here. The cost for Stem Cell Exosome Therapy is therefore the same as any Stem Cell or Stem Cell Secretome therapy; it depends on the country, what it is used for, and how many exosome injections it entails.

Does the FDA Approve Stem Cell Therapy?

Different countries have different regulations on stem cell therapy, which is why some people choose to fly out and get their treatment abroad.

For example, in the USA, the Food and Drug Administration only allows stem cell-based therapies that use bone marrow or cord blood to treat cancers.

What’s important to bear in mind is that you have to make sure that the stem cell clinic you’re considering is doing everything ethically and legally. There have been cases in Canada where stem cell clinics are recklessly advertising treatments without following industry standards. This begs the question — how do you even know if a stem cell clinic is legitimate?

Here are several signs that would indicate that a clinic is operating legally and ethically:

  • They employ doctors and nurses who specialize in stem cell-based treatments.
  • They are very transparent about their procedures which are listed on their website.
  • They follow the laws in the country where they are based.
  • They offer you a full consultation or diagnosis first before starting with any kind of procedure.

Does Health Insurance Cover Stem Cell Therapy?

Many insurance companies treat stem cell therapy as an “experimental procedure” and therefore, is not covered by them.

It’s best to contact the clinic of your choice to find out if your health insurance is considered in their payment scheme.

Why are Stem Cell Therapies Expensive?

As previously mentioned, stem cell-based therapies involve a host of individual procedures that must be carried out by doctors who are experts in this field. Stem cell transplants, for example, cannot be compared to blood transfusion and stem cell injections are not as simple as flu shots.

Another reason they are valued so highly is due to the level of research surrounding stem cells themselves. It is a young field with exciting developments occurring all the time, which clinics, in turn, aim to implement for their patients.

Additionally, in order to make the treatment safe, a lot of laboratory tests are required. These tests are typically very costly. This will increase the overall cost of stem cell therapies.

What Countries use Stem Cell Therapy?

Many countries use stem cell therapies, but each country is unique in terms of regulations and restrictions.

In Germany, Ireland, Portugal, Austria, Italy and Finland, the use of embryonic stem cells in any procedure is strictly prohibited. While some countries do not allow research with human embryos, these types of studies are allowed in countries such as the United Kingdom, Spain, Greece and Sweden.

Some of the more popular countries that patients visit to undergo stem cell-based treatments include Mexico, Panama, Ukraine, China and India.

The main reason is costs that appear lower by international standards, which may also result from the lower regulatory hurdles in some of these countries. The less regulatory supervision there is, the cheaper treatments can be offered. However, the safety of such treatments is not necessarily guaranteed.

In Germany very strict regulations must be adhered to. For this very reason, Germany is known for the fact that clinics and doctors work to the highest quality standards and produce safe drugs. This quality usually comes at a price. The effort to comply with the legal requirements is reflected in the pricing. In return, you receive a high-quality treatment that has been confirmed as safe by the authorities.

In Europe and the USA, treatment costs vary depending on whether it is a one-time or continuous treatment.

A one-time treatment with Bone Marrow Concentrate (BMC) can cost 5000 - 10000 €. The cost of combined treatment with BMC and platelet rich plasma (PRP) costs between 7000 and 8000 €. The addition of PRP is intended to prolong the effects of BMC to achieve greater effects.

At the Anova Institute for Regenerative Medicine, the cost of a single treatment with BMC is approximately 6900 €.

Multiple treatments with MSEC can cost up to 35000 €, depending on the number of treatments. At Anova IRM, this stem cell therapy includes ten individual treatments.

The perfect example would be ANOVA Institute for Regenerative Medicine, which is held to the highest standards. All treatment plans are personalized per client, following a comprehensive diagnosis. While our exact rates are not published online, feel free to send us a message and start your healing today.

  1. Georg Hansmann, Philippe Chouvarine, Franziska Diekmann, Martin Giera, Markus Ralser, Michael Mülleder, Constantin von Kaisenberg, Harald Bertram, Ekaterina Legchenko & Ralf Hass "Human umbilical cord mesenchymal stem cell-derived treatment of severe pulmonary arterial hypertension". Nature Cardiovascular Research volume 1, pages568–576 (2022).
  2. Murphy JM, Fink DJ, Hunziker EB, et al. Stem cell therapy in a caprine model of osteoarthritis . Arthritis Rheum. 2003;48:3464–74.
  3. Lee KB, Hui JH, Song IC, Ardany L, et al. Injectable mesenchymal stem cell therapy for large cartilage defects—a porcine model. Stem Cell. 2007;25:2964–71.
  4. Saw KY, Hussin P, Loke SC, et al. Articular cartilage regeneration with autologous marrow aspirate and hyaluronic acid: an experimental study in a goat model. Arthroscopy . 2009;25(12):1391–400.
  5. Black L, Gaynor J, Adams C, et al. Effect of intra-articular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther. 2008;9:192-200.
  6. Centeno C, Busse D, Kisiday J, et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343–53.
  7. Centeno C, Kisiday J, Freeman M, et al. Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: a case study. Pain Physician. 2006;9:253–6.
  8. Centeno C, Schultz J, Cheever M. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell. 2011;5(1):81–93.
  9. Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose derived stem cells: a case series. J Med Case Rep. 2001;5:296.
  10. Kuroda R, Ishida K, et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage. 2007;15:226–31.
  11. Emadedin M, Aghdami N, Taghiyar L, et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med. 2012;15(7):422–8.
  12. Saw KY et al. Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy. 2013;29(4):684–94.
  13. Vangsness CT, Farr J, Boyd J, et al. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy. J Bone Joint Surg. 2014;96(2):90–8.
  14. Freitag, Julien, et al. Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy–a review. BMC musculoskeletal disorders 17.1 (2016): 230.
  15. Maumus, Marie, Christian Jorgensen, and Danièle Noël. " Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. " Biochimie 95.12 (2013): 2229-2234.
  16. Dostert, Gabriel, et al. " How do mesenchymal stem cells influence or are influenced by microenvironment through extracellular vesicles communication?. " Frontiers in Cell and Developmental Biology 5 (2017).
  17. Chaparro, Orlando, and Itali Linero. " Regenerative Medicine: A New Paradigm in Bone Regeneration. " (2016).
  18. Toh, Wei Seong, et al. " MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment. " Seminars in Cell & Developmental Biology. Academic Press, 2016.
  19. Chaparro, Orlando, and Itali Linero. " Regenerative Medicine: A New Paradigm in Bone Regeneration. " (2016).
  20. S. Koelling, J. Kruegel, M. Irmer, J.R. Path, B. Sadowski, X. Miro, et al., Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis , Cell Stem Cell 4 (2009) 324–335.
  21. B.A. Jones, M. Pei, Synovium-Derived stem cells: a tissue-Specific stem cell for cartilage engineering and regeneration , Tissue Eng. B: Rev. 18 (2012) 301–311.
  22. W. Ando, J.J. Kutcher, R. Krawetz, A. Sen, N. Nakamura, C.B. Frank, et al., Clonal analysis of synovial fluid stem cells to characterize and identify stable mesenchymal stromal cell/mesenchymal progenitor cell phenotypes in a porcine model: a cell source with enhanced commitment to the chondrogenic lineage, Cytotherapy 16 (2014) 776–788.
  23. K.B.L. Lee, J.H.P. Hui, I.C. Song, L. Ardany, E.H. Lee, Injectable mesenchymal stem cell therapy for large cartilage defects—a porcine model, Stem Cells 25 (2007) 2964–2971.
  24. W.-L. Fu, C.-Y. Zhou, J.-K. Yu, A new source of mesenchymal stem cells for articular cartilage repair: mSCs derived from mobilized peripheral blood share similar biological characteristics in vitro and chondrogenesis in vivo as MSCs from bone marrow in a rabbit model , Am. J. Sports Med. 42 (2014) 592–601.
  25. X. Xie, Y. Wang, C. Zhao, S. Guo, S. Liu, W. Jia, et al., Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration , Biomaterials 33 (2012) 7008–7018.
  26. E.-R. Chiang, H.-L. Ma, J.-P. Wang, C.-L. Liu, T.-H. Chen, S.-C. Hung, Allogeneic mesenchymal stem cells in combination with hyaluronic acid for the treatment of osteoarthritis in rabbits , PLoS One 11 (2016) e0149835.
  27. H. Nejadnik, J.H. Hui, E.P. Feng Choong, B.-C. Tai, E.H. Lee, Autologous bone marrow–derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study , Am. J. Sports Med. 38 (2010) 1110–1116.
  28. I. Sekiya, T. Muneta, M. Horie, H. Koga, Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects , Clin. Orthop. Rel. Res. 473 (2015) 2316–2326.
  29. Y.S. Kim, Y.J. Choi, Y.G. Koh, Mesenchymal stem cell implantation in knee osteoarthritis: an assessment of the factors influencing clinical outcomes , Am. J. Sports Med. 43 (2015) 2293–2301.
  30. W.-L. Fu, Y.-F. Ao, X.-Y. Ke, Z.-Z. Zheng, X. Gong, D. Jiang, et al., Repair of large full-thickness cartilage defect by activating endogenous peripheral blood stem cells and autologous periosteum flap transplantation combined with patellofemoral realignment , Knee 21 (2014) 609–612.
  31. Y.-G. Koh, O.-R. Kwon, Y.-S. Kim, Y.-J. Choi, D.-H. Tak, Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial , Arthrosc. J. Arthrosc. Relat. Surg. 32 (2016) 97–109.
  32. T.S. de Windt, L.A. Vonk, I.C.M. Slaper-Cortenbach, M.P.H. van den Broek, R. Nizak, M.H.P. van Rijen, et al., Allogeneic mesenchymal stem cells stimulate cartilage regeneration and are safe for single-Stage cartilage repair in humans upon mixture with recycled autologous chondrons , Stem Cells (2016) (n/a-n/a).
  33. L. da Silva Meirelles, A.M. Fontes, D.T. Covas, A.I. Caplan, Mechanisms involved in the therapeutic properties of mesenchymal stem cells , Cytokine Growth Factor Rev. 20 (2009) 419–427.
  34. W.S. Toh, C.B. Foldager, M. Pei, J.H.P. Hui, Advances in mesenchymal stem cell-based strategies for cartilage repair and regeneration , Stem Cell Rev. Rep. 10 (2014) 686–696.
  35. R.C. Lai, F. Arslan, M.M. Lee, N.S.K. Sze, A. Choo, T.S. Chen, et al., Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury , Stem Cell Res. 4 (2010) 214–222.
  36. S. Zhang, W.C. Chu, R.C. Lai, S.K. Lim, J.H.P. Hui, W.S. Toh, Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration, Osteoarthr . Cartil. 24 (2016) 2135–2140.
  37. S. Zhang, W. Chu, R. Lai, J. Hui, E. Lee, S. Lim, et al., 21 – human mesenchymal stem cell-derived exosomes promote orderly cartilage regeneration in an immunocompetent rat osteochondral defect model , Cytotherapy 18 (2016) S13.
  38. C.T. Lim, X. Ren, M.H. Afizah, S. Tarigan-Panjaitan, Z. Yang, Y. Wu, et al., Repair of osteochondral defects with rehydrated freeze-dried oligo[poly(ethylene glycol) fumarate] hydrogels seeded with bone marrow mesenchymal stem cells in a porcine model
  39. A. Gobbi, G. Karnatzikos, S.R. Sankineani, One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee , Am. J. Sports Med. 42 (2014) 648–657.
  40. A. Gobbi, C. Scotti, G. Karnatzikos, A. Mudhigere, M. Castro, G.M. Peretti, One-step surgery with multipotent stem cells and Hyaluronan-based scaffold for the treatment of full-thickness chondral defects of the knee in patients older than 45 years , Knee Surg. Sports Traumatol. Arthrosc. (2016) 1–8.
  41. A. Gobbi, G. Karnatzikos, C. Scotti, V. Mahajan, L. Mazzucco, B. Grigolo, One-step cartilage repair with bone marrow aspirate concentrated cells and collagen matrix in full-thickness knee cartilage lesions: results at 2-Year follow-up , Cartilage 2 (2011) 286–299.
  42. K.L. Wong, K.B.L. Lee, B.C. Tai, P. Law, E.H. Lee, J.H.P. Hui, Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up , Arthrosc. J. Arthrosc. Relat. Surg. 29 (2013) 2020–2028.
  43. J.M. Hare, J.E. Fishman, G. Gerstenblith, et al., Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the poseidon randomized trial, JAMA 308 (2012) 2369–2379.
  44. L. Wu, J.C.H. Leijten, N. Georgi, J.N. Post, C.A. van Blitterswijk, M. Karperien, Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation , Tissue Eng. A 17 (2011) 1425–1436.
  45. L. Wu, H.-J. Prins, M.N. Helder, C.A. van Blitterswijk, M. Karperien, Trophic effects of mesenchymal stem cells in chondrocyte Co-Cultures are independent of culture conditions and cell sources , Tissue Eng. A 18 (2012) 1542–1551.
  46. S.K. Sze, D.P.V. de Kleijn, R.C. Lai, E. Khia Way Tan, H. Zhao, K.S. Yeo, et al., Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells , Mol. Cell. Proteomics 6 (2007) 1680–1689.
  47. M.B. Murphy, K. Moncivais, A.I. Caplan, Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine , Exp. Mol. Med. 45 (2013) e54.
  48. M.J. Lee, J. Kim, M.Y. Kim, Y.-S. Bae, S.H. Ryu, T.G. Lee, et al., Proteomic analysis of tumor necrosis factor--induced secretome of human adipose tissue-derived mesenchymal stem cells , J. Proteome Res. 9 (2010) 1754–1762.
  49. S. Bruno, C. Grange, M.C. Deregibus, R.A. Calogero, S. Saviozzi, F. Collino, et al., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury, J. Am. Soc. Nephrol. 20 (2009) 1053–1067.
  50. M. Yá˜nez-Mó, P.R.-M. Siljander, Z. Andreu, A.B. Zavec, F.E. Borràs, E.I. Buzas, et al. Biological properties of extracellular vesicles and their physiological functions (2015).
  51. C. Lawson, J.M. Vicencio, D.M. Yellon, S.M. Davidson, Microvesicles and exosomes: new players in metabolic and cardiovascular disease , J. Endocrinol. 228 (2016) R57–R71.
  52. A.G. Thompson, E. Gray, S.M. Heman-Ackah, I. Mager, K. Talbot, S.E. Andaloussi, et al., Extracellular vesicles in neurodegenerative diseas—pathogenesis to biomarkers, Nat. Rev. Neurol. 12 (2016) 346–357.
  53. I.E.M. Bank, L. Timmers, C.M. Gijsberts, Y.-N. Zhang, A. Mosterd, J.-W. Wang, et al., The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease , Expert Rev. Mol. Diagn. 15 (2015) 1577–1588.
  54. T. Kato, S. Miyaki, H. Ishitobi, Y. Nakamura, T. Nakasa, M.K. Lotz, et al., Exosomes from IL-1 stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes , Arthritis. Res. Ther. 16 (2014) 1–11.
  55. R.W.Y. Yeo, S.K. Lim, Exosomes and their therapeutic applications, in: C. Gunther, A. Hauser, R. Huss (Eds.), Advances in Pharmaceutical Cell TherapyPrinciples of Cell-Based Biopharmaceuticals, World Scientific, Singapore, 2015, pp. 477–491.
  56. X. Qi, J. Zhang, H. Yuan, Z. Xu, Q. Li, X. Niu, et al., Exosomes secreted by human-Induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats , Int. J. Biol. Sci. 12 (2016) 836–849.
  57. R.C. Lai, F. Arslan, S.S. Tan, B. Tan, A. Choo, M.M. Lee, et al., Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles , J. Mol. Cell. Cardiol. 48 (2010) 1215–1224.
  58. Y. Zhou, H. Xu, W. Xu, B. Wang, H. Wu, Y. Tao, et al., Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro , Stem Cell Res. Ther. 4 (2013) 1–13.
  59. Y. Qin, L. Wang, Z. Gao, G. Chen, C. Zhang, Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo , Sci. Rep. 6 (2016) 21961.
  60. M. Nakano, K. Nagaishi, N. Konari, Y. Saito, T. Chikenji, Y. Mizue, et al., Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes , Sci. Rep. 6 (2016) 24805.
  61. K. Nagaishi, Y. Mizue, T. Chikenji, M. Otani, M. Nakano, N. Konari, et al., Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes , Sci. Rep. 6 (2016) 34842.
  62. S.R. Baglio, K. Rooijers, D. Koppers-Lalic, F.J. Verweij, M. Pérez Lanzón, N. Zini, et al., Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species , Stem Cell Res. Ther. 6 (2015) 1–20.
  63. T. Chen, R. Yeo, F. Arslan, Y. Yin, S. Tan, Efficiency of exosome production correlates inversely with the developmental maturity of MSC donor, J. Stem Cell Res. Ther. 3 (2013) 2.
  64. R.C. Lai, S.S. Tan, B.J. Teh, S.K. Sze, F. Arslan, D.P. de Kleijn, et al., Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome , Int. J. Proteomics 2012 (2012) 971907.
  65. T.S. Chen, R.C. Lai, M.M. Lee, A.B.H. Choo, C.N. Lee, S.K. Lim, Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs , Nucleic Acids Res. 38 (2010) 215–224.
  66. R.W. Yeo, R.C. Lai, K.H. Tan, S.K. Lim, Exosome: a novel and safer therapeutic refinement of mesenchymal stem cell, J. Circ. Biomark. 1 (2013) 7.
  67. R.C. Lai, R.W. Yeo, S.K. Lim, Mesenchymal stem cell exosomes, Semin. Cell Dev. Biol. 40 (2015) 82–88.
  68. B. Zhang, R.W. Yeo, K.H. Tan, S.K. Lim, Focus on extracellular vesicles: therapeutic potential of stem cell-derived extracellular vesicles , Int. J. Mol. Sci. 17 (2016) 174.
  69. Hu G-w, Q. Li, X. Niu, B. Hu, J. Liu, Zhou S-m, et al., Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice , Stem Cell Res. Ther. 6 (2015) 1–15.
  70. J. Zhang, J. Guan, X. Niu, G. Hu, S. Guo, Q. Li, et al., Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis , J. Transl. Med. 13 (2015) 1–14.
  71. B. Zhang, M. Wang, A. Gong, X. Zhang, X. Wu, Y. Zhu, et al., HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing, Stem Cells 33 (2015) 2158–2168.
  72. B. Zhang, Y. Yin, R.C. Lai, S.S. Tan, A.B.H. Choo, S.K. Lim, Mesenchymal stem cells secrete immunologically active exosomes , Stem Cells Dev. 23 (2013) 1233–1244.
  73. C.Y. Tan, R.C. Lai, W. Wong, Y.Y. Dan, S.-K. Lim, H.K. Ho, Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models , Stem Cell Res. Ther. 5 (2014) 1–14.
  74. C. Lee, S.A. Mitsialis, M. Aslam, S.H. Vitali, E. Vergadi, G. Konstantinou, et al., Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension , Circulation 126 (2012) 2601–2611.
  75. B. Yu, H. Shao, C. Su, Y. Jiang, X. Chen, L. Bai, et al., Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1 , Sci. Rep. 6 (2016) 34562.
  76. Jo CH, Lee YG, Shin WH, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof of concept clinical trial. Stem Cells. 2014;32(5):1254–66.
  77. Vega, Aurelio, et al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99(8):1681–90.
  78. Davatchi F, Sadeghi-Abdollahi B, Mohyeddin M, et al. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis. 2011;14(2):211–5
  79. Hernigou P, Flouzat Lachaniette CH, Delambre J, et al. Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case- controlled study. Int Orthop. 2014;38(9):1811–1818
  80. Galli D, Vitale M, Vaccarezza M. Bone marrow-derived mesenchymal cell differentiation toward myogenic lineages: facts and perspectives. Biomed Res Int. 2014;2014:6.
  81. Beitzel K, Solovyova O, Cote MP, et al. The future role of mesenchymal Stem cells in The management of shoulder disorders . Arthroscopy. 2013;29(10):1702–1711.
  82. Isaac C, Gharaibeh B, Witt M, Wright VJ, Huard J. Biologic approaches to enhance rotator cuff healing after injury. J Shoulder Elbow Surg. 2012;21(2):181–190.
  83. Malda, Jos, et al. " Extracellular vesicles [mdash] new tool for joint repair and regeneration. " Nature Reviews Rheumatology (2016).

  1. Xu, Ming, et al. " Transplanted senescent cells induce an osteoarthritis-like condition in mice. " The Journals of Gerontology Series A: Biological Sciences and Medical Sciences (2016): glw154.
  2. McCulloch, Kendal, Gary J. Litherland, and Taranjit Singh Rai. " Cellular senescence in osteoarthritis pathology ." Aging Cell (2017).

Patient Services at ANOVA Institute for Regenerative Medicine

  • Located in the center of Germany, quick access by car or train from anywhere in Europe
  • Simple access worldwide, less than 20 minutes from Frankfurt Airport
  • Individualized therapy with state-of-the-art stem cell products
  • Individually planned diagnostic work-up which include world-class MRI and CT scans
  • German high quality standard on safety and quality assurance
  • Personal service with friendly, dedicated Patient Care Managers
  • Scientific collaborations with academic institutions to assure you the latest regenerative medical programs